Ms. Michele Hamilton, NCS RNAPRN BC Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 110 Whitpain Hills, Michele Hamilton Cns, Blue Bell, PA 19422 Phone: 610-279-2649 |
News Archive
In a new paper published by The Journal of Alzheimer's Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer's disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer's disease.
A new app developed by the University of Wisconsin-Milwaukee and the Medical College of Wisconsin helps doctors make better decisions during brain surgeries.
A Democratic senator dismissed those fears Tuesday, saying cameras would not cheapen the high court's proceedings. "I'm trying to picture Ruth Bader Ginsburg turning into Judge Judy. I just don't think it's going to happen," Sen. Amy Klobuchar (D-Minn.) said during a hearing on the subject Tuesday.
Videos and creative uses of other visuals provide a novel way to obtain informed consent during clinical trials to improve participants' understanding and retention of trial information, according to a study by Nemours Children's Health System presented at the American Thoracic Society (ATS) Annual Conference.
The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.
› Verified 2 days ago